Why Masimo (MASI) is a Top Growth Stock for the Long-Term

Zacks
21 Mar

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.

While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.

Why This 1 Growth Stock Should Be On Your Watchlist

Different than value or momentum investors, growth-oriented investors are concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, they'll want to focus on the Growth Style Score, which analyzes characteristics like projected and historical earnings, sales, and cash flow to find stocks that will see sustainable growth over time.

Masimo (MASI)

Irvine, CA-based Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The company has two segments: Healthcare revenues (62.3% of FY23 revenues, down 4.8% from FY22) and Non-healthcare revenues (37.7%, up 11.1%).

MASI sits at a Zacks Rank #1 (Strong Buy), holds a Growth Style Score of A, and has a VGM Score of B. Earnings and sales are forecasted to increase 20% and 27.6% year-over-year, respectively.

Five analysts revised their earnings estimate upwards in the last 60 days for fiscal 2025. The Zacks Consensus Estimate has increased $0.67 to $5.28 per share. MASI boasts an average earnings surprise of 14.4%.

On a historic basis, Masimo has generated cash flow growth of 10.7%, and is expected to report cash flow expansion of 13% this year.

Investors should take the time to consider MASI for their portfolios due to its solid Zacks Rank rating, notable growth metrics, and impressive Growth and VGM Style Scores.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Masimo Corporation (MASI) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10